Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Nov 29, 2023. (Total: 223447Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Thrombosis and ASXL1[original query]
Genetic Risk Assessment in Myeloproliferative Neoplasms.
Mayo Clinic proceedings 2017 8 92 (8): 1283-1290.
Tefferi Ayalew, Vannucchi Alessandro Mar
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients.
Blood cancer journal 2017 12 7 (12): 662.
Cerquozzi S, Barraco D, Lasho T, Finke C, Hanson C A, Ketterling R P, Pardanani A, Gangat N, Tefferi
ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients.
British journal of haematology 2020 Feb .
Andréasson Björn, Pettersson Helna, Wasslavik Carina, Johansson Peter, Palmqvist Lars, Asp Jul
Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases.
Blood cancer journal 2022 3 12 (3): 44.
Gangat Naseema, Jadoon Yamna, Szuber Natasha, Hanson Curtis A, Wolanskyj-Spinner Alexandra P, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal
Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients.
Blood cancer journal 2022 2 12 (2): 26.
Mangaonkar Abhishek A, Lasho Terra L, Ketterling Rhett P, Reichard Kaaren K, Gangat Naseema, Al-Kali Aref, Begna Kebede H, Pardanani Animesh, Al Ali Najla H, Talati Chetasi, Sallman David, Padron Eric, Patnaik Mrinal M, Tefferi Ayalew, Komrokji Ra
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.
Journal of cancer research and clinical oncology 2022 Oct .
Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 5 JCO2201935.
Claire N Harrison, Jyoti Nangalia, Rebecca Boucher, Aimee Jackson, Christina Yap, Jennifer O'Sullivan, Sonia Fox, Isaak Ailts, Amylou C Dueck, Holly L Geyer, Ruben A Mesa, William G Dunn, Eugene Nadezhdin, Natalia Curto-Garcia, Anna Green, Bridget Wilkins, Jason Coppell, John Laurie, Mamta Garg, Joanne Ewing, Steven Knapper, Josephine Crowe, Frederick Chen, Ioannis Koutsavlis, Anna Godfrey, Siamak Arami, Mark Drummond, Jennifer Byrne, Fiona Clark, Carolyn Mead-Harvey, Elizabeth Joanna Baxter, Mary Frances McMullin, Adam J Me
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort.
Annals of hematology 2023 4 .
Daniele Cattaneo, Cristina Bucelli, Alfredo Marchetti, Marta Lionetti, Elisa Fermo, Valentina Bellani, Claudio De Magistris, Akihiro Maeda, Alessio Marella, Massimo Primignani, Dario Consonni, Umberto Gianelli, Antonino Neri, Luca Baldini, Niccolò Bolli, Alessandra Iur
Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients.
British journal of haematology 2023 11 .
Chiho Furuya, Soji Morishita, Yoshinori Hashimoto, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komat
TOP